LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
TARA Protara Therapeutics
- 5.510
- +0.010+0.18%
Close Dec 27 16:00 ET
- 5.510
- 0.0000.00%
Post 16:07 ET
189.10MMarket Cap-2.09P/E (TTM)
5.580High5.345Low347.90KVolume5.500Open5.500Pre Close1.90MTurnover1.26%Turnover RatioLossP/E (Static)34.32MShares10.48052wk High2.31P/B152.02MFloat Cap1.59552wk Low--Dividend TTM27.59MShs Float800.000Historical High--Div YieldTTM4.27%Amplitude1.040Historical Low5.466Avg Price1Lot Size
Protara Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -28.55%-8.43M | 18.29%-7.69M | 19.47%-10.38M | -41.95%-37.56M | -73.10%-8.7M | -22.70%-6.56M | -83.64%-9.41M | -17.58%-12.89M | 23.32%-26.46M | 27.23%-5.03M |
| Net income from continuing operations | -13.78%-11.22M | 15.77%-9.51M | -22.66%-11.1M | 38.71%-40.42M | 73.77%-10.22M | -28.20%-9.86M | -32.26%-11.29M | 15.90%-9.05M | -39.58%-65.95M | -280.98%-38.97M |
| Depreciation and amortization | 6.33%84K | 6.41%83K | 7.79%83K | 37.50%341K | 42.67%107K | 23.44%79K | 47.17%78K | 37.50%77K | 111.97%248K | 111.40%75K |
| Other non cash items | 807.14%254K | -26.90%250K | -27.86%246K | -25.84%1.01M | -11.70%302K | -91.79%28K | 0.00%342K | 0.00%341K | 30.10%1.37M | --342K |
| Change In working capital | -1.34%1.85M | 2,394.74%436K | 86.63%-771K | -867.90%-4.14M | -109.19%-227K | 717.47%1.87M | -102.59%-19K | -99.34%-5.77M | 204.46%539K | 337.77%2.47M |
| -Change in prepaid assets | -860.00%-950K | -98.61%57K | 107.08%435K | -577.36%-1.27M | -6.30%654K | -55.83%125K | 772.55%4.1M | -418.13%-6.15M | 163.40%265K | 273.26%698K |
| -Change in payables and accrued expense | 61.56%2.95M | 107.50%112K | -201.68%-665K | -75.13%343K | -131.96%-643K | 808.46%1.83M | -341.75%-1.49M | 145.04%654K | 123.86%1.38M | 237.02%2.01M |
| -Change in other current assets | 258.33%95K | 122.22%510K | -618.97%-301K | -1,136.04%-2.3M | -103.30%-3K | -177.92%-60K | -9,462.50%-2.3M | -25.64%58K | -24.75%222K | 10.98%91K |
| -Change in other current liabilities | -1,205.26%-248K | 26.59%-243K | 27.71%-240K | 30.90%-917K | 29.22%-235K | 94.28%-19K | 0.00%-331K | 0.00%-332K | -31.52%-1.33M | -9.93%-332K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -28.55%-8.43M | 18.29%-7.69M | 19.47%-10.38M | -41.95%-37.56M | -73.10%-8.7M | -22.70%-6.56M | -83.64%-9.41M | -17.58%-12.89M | 23.32%-26.46M | 27.23%-5.03M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -560.80%-29.39M | -86.82%2.95M | 134.28%23.1M | 255.23%53.11M | 179.14%14.52M | -66.52%6.38M | 65.54%22.35M | 1,223.49%9.86M | 115.22%14.95M | -1,071.15%-18.35M |
| Net PPE purchase and sale | 78.38%-8K | -2,650.00%-55K | --0 | 62.50%-45K | --0 | 55.42%-37K | 90.00%-2K | 45.45%-6K | 79.87%-120K | 86.36%-6K |
| Net investment purchase and sale | -558.02%-29.38M | -86.58%3M | 134.14%23.1M | 252.70%53.15M | 179.16%14.52M | -66.47%6.42M | 65.31%22.35M | 1,205.03%9.87M | 115.44%15.07M | -1,048.73%-18.34M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -560.80%-29.39M | -86.82%2.95M | 134.28%23.1M | 255.23%53.11M | 179.14%14.52M | -66.52%6.38M | 65.54%22.35M | 1,223.49%9.86M | 115.22%14.95M | -1,071.15%-18.35M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 42.09M | -18.75%-76K | -1.11%-91K | 0 | -50.00%-27K | 0 | 11.11%-64K | 60.53%-90K | 0 |
| Net common stock issuance | --0 | 65,587.50%42.04M | -18.75%-76K | -1.11%-91K | ---91K | --0 | --64K | 11.11%-64K | 60.53%-90K | --0 |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | --0 | ---- | ---- | ---- | ---- | ---27K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --42.09M | -18.75%-76K | -1.11%-91K | --0 | -50.00%-27K | --0 | 11.11%-64K | 60.53%-90K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 160.13%90.33M | 143.23%52.98M | 62.15%40.33M | -31.80%24.87M | -28.46%34.51M | 0.47%34.72M | -16.81%21.78M | -31.80%24.87M | -78.47%36.47M | 16.28%48.24M |
| Current changes in cash | -17,911.43%-37.82M | 188.57%37.35M | 508.96%12.65M | 233.30%15.46M | 124.89%5.82M | -101.53%-210K | 54.47%12.94M | 69.95%-3.09M | 91.28%-11.6M | -365.74%-23.37M |
| End cash Position | 52.12%52.5M | 160.13%90.33M | 143.23%52.98M | 62.15%40.33M | 62.15%40.33M | -28.46%34.51M | 0.47%34.72M | -16.81%21.78M | -31.80%24.87M | -31.80%24.87M |
| Free cash flow | -27.95%-8.44M | 17.73%-7.74M | 19.51%-10.38M | -41.48%-37.6M | -72.89%-8.7M | -21.51%-6.6M | -82.97%-9.41M | -17.52%-12.89M | 24.28%-26.58M | 27.61%-5.03M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |